Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01323231 · ClinicalTrials.gov registry record · Phase 1
XY-Zone Program Evaluation: A School-Based Dropout Prevention Program for At-Risk Youth
A Phase 1 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 1
- Development phase
- 91
- Enrollment target
NCT01323231 is a Phase 1 study that has completed, run by University of Texas at Austin. The registered enrollment target is 91 participants.
The verdict
NCT01323231, a Phase 1 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 91 participants
- Enrollment target
Study Summary
The objective of this study is to build upon preliminary research and conduct a pilot feasibility randomized controlled trial on a promising culturally-grounded and gender-specific treatment program, the XY-Zone. The central hypothesis underlying this study purports that through receiving the XY-Zone treatment, adolescents will decrease their risk for dropping out of school. This hypothesis is supported by two years of preliminary data investigating the effectiveness of the XY-Zone. To test the central hypothesis, the following specific aims will be pursued: 1. Identify school dropout risk and protective factors (protective factors defined as: adult support and peer support; risk factors defined as: low school attendance, inability to achieve grade promotion, substance use, delinquency, school disconnectedness, misbehavior, disconnection from healthy peers) directly changed as a result of XY-Zone intervention. 2. Determine the extent to which moderating variables (affective strength, duration in the program, family functioning, interpersonal strength, intrapersonal strength, level achieved in the program, and resiliency) effect change in outcome variables (risk and protective factors). 3. Identify participants' beliefs about the impact of the mechanisms of change (respect, responsibility, relationship, role modeling, and reaching out) on outcome variables (risk and protective factors ) to enrich understanding of quantitative data.
Interventions
- BEHAVIORAL XY-Zone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2011-08 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01323231
The ClinicalTrials.gov registry entry for NCT01323231 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which XY-Zone is the first listed.
NCT01323231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01323231 about?
NCT01323231 is a clinical study titled "XY-Zone Program Evaluation: A School-Based Dropout Prevention Program for At-Risk Youth". The objective of this study is to build upon preliminary research and conduct a pilot feasibility randomized controlled trial on a promising culturally-grounded and gender-specific treatment program, the XY-Zone. The central hypothesis underlying this study purports that through receiving the XY-Zon...
What is the current status of trial NCT01323231?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 91 participants. The study started on 2011-08. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01323231?
The interventions under investigation include: XY-Zone (BEHAVIORAL).
Who is sponsoring clinical trial NCT01323231?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.